Business Medical Dialogues
    • facebook
    • twitter
    Login Register
    • facebook
    • twitter
    Login Register
    • Medical Dialogues
    • Speciality Dialogues
    • Education Dialogues
    • Medical Jobs
    • Medical Matrimony
    • MD Brand Connect
    Business Medical Dialogues
    • News
        • Financial Results
        • Hospitals & Diagnostics
        • IT / Health Venture
        • Implants / Devices
        • Insurance
        • Key Movement
        • Pharmaceuticals
        • Policy
        • Technology
        • pharma-news
    • blog
    LoginRegister
    Business Medical Dialogues
    LoginRegister
    • Home
    • News
      • Financial Results
      • Hospitals & Diagnostics
      • IT / Health Venture
      • Implants / Devices
      • Insurance
      • Key Movement
      • Pharmaceuticals
      • Policy
      • Technology
      • pharma-news
    • blog
    • Home
    • Editors Pick
    • Revenue Intelligence...

    Revenue Intelligence seizes 100 kg of ALPRAZOLAM from Vizag factory

    Written by savita thakur thakur Published On 2016-10-10T12:01:46+05:30  |  Updated On 10 Oct 2016 12:01 PM IST
    Revenue Intelligence seizes 100 kg of ALPRAZOLAM from Vizag factory

    Hyderabad : Directorate of Revenue Intelligence has seized around 100 kgs of alprazolam with a market value of Rs 2.52 crore, allegedly manufactured illicitly from a factory in Visakhapatnam, and apprehended five persons in this connection.


    On specific intelligence, officers of DRI, Visakhapatnam and Hyderabad conducted search operations at different premises located in Medak (in Telangana) and Visakhapatnam, Additional Director General M K Singh said in a release.


    During the search in the factory premises located at J N Pharmacity at Parawada (Vizag) it was found that alprazolam was being illicitly manufactured there, he said, adding that quantity of about 100 kgs of alprazolam, with market value of Rs 2.52 crore, was recovered from the factory and it was seized under the provisions of Narcotics Drugs and Psychotropic Substances (NDPS) Act.


    Apart from this, 330 litres of raw material and around 62 kgs of in-process material was also seized.


    Alprazolam is a psychotropic substance notified under the provisions of NDPS Act.


    "Five persons, who were found involved in the illicit manufacture of alprazolam and in its further sale, have been apprehended," Singh said.


    Further incriminating evidence has been recovered during the searches and investigation is on.

    alprazolamDirectorate of Revenue IntelligenceDRIM K SinghNarcotics Drugs and Psychotropic SubstancesNarcotics Drugs and Psychotropic Substances ActNDPS Act
    Source : PTI

    Disclaimer: This site is primarily intended for healthcare professionals. Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription. Use of this site is subject to our terms of use, privacy policy, advertisement policy. © 2020 Minerva Medical Treatment Pvt Ltd

    savita thakur thakur
    savita thakur thakur
      Show Full Article
      Next Story
      Similar Posts
      NO DATA FOUND

      Popular Stories

      • Email: info@medicaldialogues.in
      • Phone: 011 - 4372 0751

      Website Last Updated On : 13 Oct 2022 5:14 AM GMT
      Company
      • About Us
      • Contact Us
      • Our Team
      • Reach our Editor
      • Feedback
      • Submit Article
      Ads & Legal
      • Advertise
      • Advertise Policy
      • Terms and Conditions
      • Privacy Policy
      • Editorial Policy
      • Comments Policy
      • Disclamier
      Medical Dialogues is health news portal designed to update medical and healthcare professionals but does not limit/block other interested parties from accessing our general health content. The health content on Medical Dialogues and its subdomains is created and/or edited by our expert team, that includes doctors, healthcare researchers and scientific writers, who review all medical information to keep them in line with the latest evidence-based medical information and accepted health guidelines by established medical organisations of the world.

      Any content/information on this website does not replace the advice of medical and/or health professionals and should not be construed as medical/diagnostic advice/endorsement or prescription.Use of this site is subject to our terms of use, privacy policy, advertisement policy. You can check out disclaimers here. © 2025 Minerva Medical Treatment Pvt Ltd

      © 2025 - Medical Dialogues. All Rights Reserved.
      Powered By: Hocalwire
      X
      We use cookies for analytics, advertising and to improve our site. You agree to our use of cookies by continuing to use our site. To know more, see our Cookie Policy and Cookie Settings.Ok